Young Wendy B.
SEC Form 4 insider trading activity
Young Wendy B. has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company, with disclosures dating back to 2025. 1 of those filings fall inside the rolling window. Most recent filing: Oct 22, 2026.
On the most recent filing, Young Wendy B. is listed as Director at Rapport Therapeutics, Inc. Inside the rolling window, Young Wendy B. reported 1 open-market purchase totaling $100K in RAPP and no open-market sales.
Companies traded
Other insiders at RAPP
Insider Buying
$100K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Companies
1
in the rolling window
Earlier trades
Open-market purchases and sales filed before the rolling 365-day window, kept from the original Form 4 filings.
| Date | Ticker | Type | Value |
|---|---|---|---|
| Sep 11, 2025 | RAPP | Purchase | $79K |
Frequently asked questions
How many SEC Form 4 filings has Young Wendy B. made?
Young Wendy B. has filed 2 SEC Form 4 filings (2 transaction rows) across 1 company since 2025.
Which companies does Young Wendy B. trade?
Young Wendy B. has filed SEC Form 4 disclosures for 1 company, including RAPP.
When was Young Wendy B.'s most recent SEC Form 4 filing?
Young Wendy B.'s most recent SEC Form 4 filing on Tracefour is dated Oct 22, 2026.
What is Young Wendy B.'s total buy and sell value in the current window?
Inside the rolling retention window, Young Wendy B. bought $100K and sold $0 based on SEC Form 4 filings.
What was Young Wendy B.'s largest disclosed transaction?
The largest disclosed transaction in the current window is a purchase of 3,789 RAPP shares on 2026-10-22, worth $100K, per SEC Form 4 filings.